Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

Author: Palos Isidro   Lara-Ramirez Edgar E.   Lopez-Cedillo Julio Cesar   Garcia-Perez Carlos   Kashif Muhammad   Bocanegra-Garcia Virgilio   Nogueda-Torres Benjamin   Rivera Gildardo  

Publisher: MDPI

E-ISSN: 1420-3049|22|6|1015-1015

ISSN: 1420-3049

Source: Molecules, Vol.22, Iss.6, 2017-06, pp. : 1015-1015

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content